HomeComparePSAIX vs JNJ

PSAIX vs JNJ: Dividend Comparison 2026

PSAIX yields 4.30% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PSAIX wins by $6.5K in total portfolio value
10 years
PSAIX
PSAIX
● Live price
4.30%
Share price
$10.19
Annual div
$0.44
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$26.5K
Annual income
$566.08
Full PSAIX calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — PSAIX vs JNJ

📍 PSAIX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPSAIXJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PSAIX + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
PSAIX pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PSAIX
Annual income on $10K today (after 15% tax)
$365.27/yr
After 10yr DRIP, annual income (after tax)
$481.17/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, JNJ beats the other by $222.44/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PSAIX + JNJ for your $10,000?

PSAIX: 50%JNJ: 50%
100% JNJ50/50100% PSAIX
Portfolio after 10yr
$23.3K
Annual income
$696.93/yr
Blended yield
3.00%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

PSAIX
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PSAIX buys
0
JNJ buys
0
No recent congressional trades found for PSAIX or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPSAIXJNJ
Forward yield4.30%3.36%
Annual dividend / share$0.44$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$26.5K$20.0K
Annual income after 10y$566.08$827.78
Total dividends collected$5.0K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: PSAIX vs JNJ ($10,000, DRIP)

YearPSAIX PortfolioPSAIX Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,130$429.73$10,676$355.77+$454.00PSAIX
2$12,356$446.98$11,407$389.39+$949.00PSAIX
3$13,684$463.76$12,198$426.53+$1.5KPSAIX
4$15,122$480.03$13,056$467.62+$2.1KPSAIX
5$16,677$495.77$13,987$513.12+$2.7KPSAIX
6$18,355$510.96$14,998$563.56+$3.4KPSAIX
7$20,165$525.59$16,098$619.52+$4.1KPSAIX
8$22,117$539.65$17,295$681.69+$4.8KPSAIX
9$24,218$553.15$18,599$750.82+$5.6KPSAIX
10$26,479$566.08$20,022$827.78+$6.5KPSAIX

PSAIX vs JNJ: Complete Analysis 2026

PSAIXStock

The investment seeks total return which exceeds that of its benchmarks, consistent with prudent investment management. The fund invests at least 80% of its assets in Fixed Income Instruments that are economically tied to at least three countries (one of which may be the United States), which may be represented by forwards or derivatives such as options, futures contracts, or swap agreements. It may invest up to 10% of its total assets in preferred securities. The fund may invest, without limitation, in derivative instruments, such as options, futures contracts or swap agreements, or in mortgage- or asset-backed securities.

Full PSAIX Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this PSAIX vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PSAIX vs SCHDPSAIX vs JEPIPSAIX vs OPSAIX vs KOPSAIX vs MAINPSAIX vs ABBVPSAIX vs MRKPSAIX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.